Atlas Trials

Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia

Clinical trial NCT01079507 · UNKNOWN

Trial details

NCT number
NCT01079507
Sponsor
Samsung Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Acute Lymphoblastic Leukemia
Start date
2010-02-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.